Loading
VP
Valeo Pharma Inc. Stock: price and insider trades · Canada
Valeo Pharma Inc.: what insiders have been doing
This page follows insider dealings at Valeo Pharma Inc. as filed with SEDI. The past year has been quiet: not a single insider filing for Valeo Pharma Inc. The previous disclosure was published on 11 November 2024.
Over the whole record (from 2019), the tally stands at 71 purchases and 5 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
145
Thresholds
n/a
Buy Volume
€940,699
71 ops. · all time
Sell Volume
€93,626
5 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 11 November 2024
Declarations145 total
Common Shares Class ATSXSEDI:4400341
Common Shares Class ATSXSEDI:4400338
Common Shares Class ATSXSEDI:4285447
Common Shares Class ATSXSEDI:4259331
8,572 shares@ CA$0.265100.0% of flowCommon Shares Class ATSXSEDI:4259147
Common Shares Class ATSXSEDI:4258913
19,394 sharesCommon Shares Class ATSXSEDI:4214626
Common Shares Class ATSXSEDI:4214624
13,393 sharesCommon Shares Class ATSXSEDI:4214630
Common Shares Class ATSXSEDI:4212279
650,000 sharesCommon Shares Class ATSXSEDI:4187906
650,000 sharesCommon Shares Class ATSXSEDI:4188193
650,000 sharesCommon Shares Class ATSXSEDI:4187164
520,000 shares@ CA$0.2510.8% of flowCommon Shares Class ATSXSEDI:4186749
520,000 shares@ CA$0.256.0% of flowCommon Shares Class ATSXSEDI:4186739
892,857 shares@ CA$0.2822.9% of flowCommon Shares Class ATSXSEDI:4181944
100,000 shares@ CA$0.324.1% of flowCommon Shares Class ATSXSEDI:4171529
Canonical exit: 16 Nov 2023 (T+90)
100,000 shares@ CA$1.00Common Shares Class ATSXSEDI:4162108
2,600,000 shares@ CA$0.40Common Shares Class ATSXSEDI:4162103
3,419 shares@ CA$0.40Common Shares Class ATSXSEDI:4162105
46,296 sharesCommon Shares Class ATSXSEDI:4121147
27,778 sharesCommon Shares Class ATSXSEDI:4121156
37,037 sharesCommon Shares Class ATSXSEDI:4121166
27,778 sharesCommon Shares Class ATSXSEDI:4121163
Common Shares Class ATSXSEDI:4121268
25 of 145 declarations
About Valeo Pharma Inc.
Valeo Pharma Inc. is a Canadian pharmaceutical company focused on the development and commercialization of innovative pharmaceutical products. The company specializes in treatments in the fields of neurology, respiratory health, and oncology.
